Cambridge Innovation Capital
GPTKB entity
Properties (41)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Insurance_Company
|
| gptkbp:focusesOn |
Technology
Life_Sciences |
| gptkbp:founded |
2013
|
| gptkbp:hasFunding |
Sector-focused
Equity Investment Debt Investment Technology-focused Geography-focused Co-investment Convertible Debt Investment Early-stage Investment Follow-on Investment Growth-stage Investment Seed Investment Series A Investment Series B Investment Stage-focused Strategic Investment Mezzanine_Financing Direct_Investment Indirect_Investment Life_Sciences-focused Venture_Debt_Investment |
| gptkbp:hasTransportation |
gptkb:Cambridge_Epigenetix
gptkb:Ceres_Media gptkb:Sensible_Medical_Innovations Darktrace Synthego Samsara Therapeutics Sareum Sifted Siren Diagnostics Zegami |
| gptkbp:headquarteredIn |
gptkb:Cambridge,_England
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cambridge Innovation Capital
|
| gptkbp:investmentFocus |
Early-stage Companies
Growth-stage Companies |
| gptkbp:manages |
Investment Funds
|
| gptkbp:partnerships |
Research Institutions
Universities |